Summary of Key Information:

Reporting Period (Quarter/Year): Quarter and Half-Year ended September 30, 2026 (Q2 FY27)

Nature of Filing / Announcement: Outcome of Board Meeting pursuant to Regulation 30 of SEBI (LODR)

Date of Board Meeting / Approval: November 6, 2026

Audit Opinion: Unmodified (Clean) Limited Review Report issued by S R Batliboi & Associates LLP

Auditor’s Comment: No qualifications or modifications affecting earnings quality, internal controls, or going concern.

Key Financial Highlights [₹ in Crores]

Standalone Results:

Revenue from Operations:

  • Q2 FY27: ₹9,935.46 Cr (vs. Q2 FY26: ₹9,411.34 Cr | +5.6% YoY)
  • H1 FY27: ₹17,679.01 Cr (vs. H1 FY26: ₹16,412.66 Cr | +7.7% YoY)

Total Income:

  • Q2 FY27: ₹9,987.18 Cr
  • H1 FY27: ₹17,779.49 Cr

Net Profit:

  • Q2 FY27: ₹548.17 Cr (vs. Q2 FY26: ₹816.33 Cr | -32.9% YoY)
  • H1 FY27: ₹925.13 Cr (vs. H1 FY26: ₹1,324.56 Cr | -30.2% YoY)

EPS:

  • Q2 FY27 (Basic): ₹18.61
  • H1 FY27 (Basic): ₹31.41

Other Equity (as of 30 Sep 2026): ₹13,312.04 Cr

Cash and Cash Equivalents (as of 30 Sep 2026): ₹396.87 Cr

Debt: Not separately specified in the standalone balance sheet.

Consolidated Results:

Revenue from Operations:

  • Q2 FY27: ₹10,294.13 Cr (vs. Q2 FY26: ₹9,654.13 Cr | +6.6% YoY)
  • H1 FY27: ₹18,458.90 Cr (vs. H1 FY26: ₹16,696.43 Cr | +10.6% YoY)

Total Income:

  • Q2 FY27: ₹10,348.39 Cr
  • H1 FY27: ₹18,562.97 Cr

Net Profit:

  • Q2 FY27: ₹523.37 Cr (vs. Q2 FY26: ₹793.44 Cr | -34.0% YoY)
  • H1 FY27: ₹904.93 Cr (vs. H1 FY26: ₹1,295.03 Cr | -30.1% YoY)
  • Attributable to Owners: ₹914.99 Cr for H1 FY27

EPS:

  • Q2 FY27 (Basic): ₹18.14
  • H1 FY27 (Basic): ₹31.07

Other Equity (as of 30 Sep 2026): ₹13,379.89 Cr

Cash and Cash Equivalents (as of 30 Sep 2026): ₹456.88 Cr

Debt: Consolidated borrowings (Current + Non-current) stood at ₹951.03 Cr + ₹80.34 Cr = ₹1,031.37 Cr as of 30 Sep 2026.

Segment-wise Performance [₹ in Crores]

Nutrient and other allied business:

  • H1 FY27 Revenue: ₹15,993.21 Cr (Consolidated)
  • H1 FY27 Segment Result: ₹1,224.81 Cr (Consolidated)

Crop protection:

  • H1 FY27 Revenue: ₹2,559.24 Cr (Consolidated)
  • H1 FY27 Segment Result: ₹300.48 Cr (Consolidated)

The Crop Protection segment, bolstered by the acquisition of NACL Industries, showed significant revenue growth but a decline in segment result compared to the previous year.

Corporate Actions:

Dividend: Not declared in this announcement.

Share Allotment: The Company allotted 44,460 equity shares during the quarter ended 30 September 2026 pursuant to the exercise of stock options.

Other Significant Information:

Subsidy Recognition: Subsidy income is recognised based on existing Kharif NBS rates, pending notification of Rabi 2026-27 rates by the Department of Fertilizers (DoF). Necessary adjustments will be made in subsequent quarters.

Associate Company: During the quarter, NACL Industries Limited sold its entire stake in Nasense Labs Private Limited, which ceased to be an associate.

Exceptional Items: The results for the year ended 31 March 2026 included an exceptional item (impairment provision) of ₹125.15 Cr (Standalone) and ₹70.56 Cr (Consolidated) relating to the Company's Drones subsidiary business. There were no exceptional items in the current quarter.

Entities in Consolidation: The consolidated results include 24 subsidiaries, 1 joint venture, and 1 associate (till August 10, 2026).